XML 32 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Schedule of basic and diluted weighted average shares outstanding
   For the Three Months Ended
September 30,
   For the Nine Months Ended
September 30,
 
   2021   2020   2021   2020 
Numerator:                
Net income (loss)  $18,296,856   $(829,418)  $(21,360,865)  $(2,943,294)
Less: decrease in fair value of dilutive warrants   10,487,783    
-
    
-
    
-
 
Income (loss) available to common stockholders - diluted  $7,809,073   $(829,418)  $(21,360,865)  $(2,943,294)
                     
Weighted average shares outstanding (denominator for basic earnings per share)   32,727,965    16,850,379    30,491,082    16,847,069 
                     
Effects of dilutive securities:                    
Assumed exercise of stock options, treasury stock method   182,727    
-
    
-
    
-
 
Assumed exercise of warrants, treasury stock method   798,892    
-
    
-
    
-
 
Dilutive potential common shares   981,619    
-
    
-
    
-
 
                     
Weighted average shares and assumed potential common shares (denominator for diluted earnings per share, treasury method)   33,709,584    16,850,379    30,491,082    16,847,069 
                     
Basic earnings per share  $0.56   $(0.05)  $(0.70)  $(0.17)
Diluted earnings per share  $0.23   $(0.05)  $(0.70)  $(0.17)

 

Schedule of anti-dilutive
   For the Three Months Ended   For the Nine Months Ended 
   2021   2020   2021   2020 
Options   436,000    
-
    2,066,000    
-
 
Warrants   8,526,250    
-
    11,153,908    
-
 
Convertible debt(a)   
-
    586,833    
-
    586,833 
Total potentially dilutive shares   8,962,250    586,833    13,219,908    586,833